S 4472 · 119th Congress

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

This bill extends a federal program that helps speed up the development and approval of treatments for ALS (amyotrophic lateral sclerosis), a serious neurodegenerative disease. Right now, the program is set to expire in 2026, but this bill would keep it running through 2031, giving researchers and drug companies fiv…

Sponsor

Murkowski, Lisa (R-Alaska)

Introduced

2026-04-30